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Total caloric restriction (CR) without malnutrition is a well-established experimental
approach to extend life span in laboratory animals. Although CR in humans is capable of
shifting several endocrinological parameters, it is not clear where the minimum inflection
point of the U-shaped curve linking body mass index (BMI) with all-cause mortality lies.The
exact trend of this curve, when used for planning preventive strategies for public health is
of extreme importance. Normal BMI ranges from 18.5 to 24.9; many epidemiological stud-
ies show an inverse relationship between mortality and BMI inside the normal BMI range.
Other studies show that the lowest mortality in the entire range of BMI is obtained in the
overweight range (25–29.9). Reconciling the extension of life span in laboratory animals
by experimental CR with the BMI–mortality curve of human epidemiology is not trivial. In
fact, one interpretation is that the CR data are identifying a known: “excess fat is deleteri-
ous for health”; although a second interpretation may be that: “additional leanness from a
normal body weight may add health and life span delaying the process of aging.”This short
review hope to start a discussion aimed at finding the widest consensus on which weight
range should be considered the “healthiest” for our species, contributing in this way to
the picture of what is the correct life style for a long and healthy life span.
Keywords: longevity, life span, caloric restriction, dietary restriction, body weight, body mass index, mortality,
obesity paradox
INTRODUCTION
That moderation is a wise choice if we are concerned with health
is an idea that has been handed down across cultures. The Japan-
ese philosopher Kaibara Ekiken wrote about diet, advocating for
moderation in food intake for better health as early as 1713. Scien-
tifically, the first report on the health benefit of CR dates back to a
study by McCay and colleagues in 1935 (1). In their report, extreme
restriction in food intake retarded development in rats such that
rats fed a restricted diet never achieved the adult weight of their
unrestricted counterparts. Although smaller, these animals were
longer lived. The life-prolonging effect of CR is more profound
when restriction is started soon after weaning and carried out for
the entire life of the animal. Nonetheless, if started in adulthood,
so as not to effect development, the effect of CR is smaller but
still highly significant (2). Life extension by CR seems universal,
much less clear is the magnitude of life extension that varies widely
among different orders (3). Recently, using a set of 41 recombinant
inbred mouse strains originally developed for alcoholism research,
Liao et al. (4) have challenged the universality of CR even in mice,
which together with rats are by far the mammals more utilized in
CR studies. A more universal phenomenon is the decrease in body
weight that is associated with CR. When CR is started early after
development, weight of CR mice ranges from ~60 to ~85% of the
ad libitum weight (5). Weight loss is the result of both lean and fat
mass loss, although variation in fat loss is the component mostly
responsible for the high variation observed in weight loss among
different strains (6). Humans are not different. If an adult will
choose to calorically restrict its own diet, leaving everything else
in its life style unchanged, the more consistent observable result
will be a decrease in body weight.
The relationship between adult body weight and health in
human is of extreme importance in our contemporary world. At
present, a rough estimate of the “globesity” epidemic suggests that
about one of every seven people is obese, two are overweight,
and one is suffering from undernutrition (often of micronutri-
ents). The body mass index (BMI), or Quetelet index, named after
its founder Adolphe Quételet (7), is the ratio of a person’s mass
(kilogram) to height squared (meter square) and is a widely used
parameter for determining human body shape. In analysis of epi-
demiological data, the relationship between all-cause mortality
and BMI gives a U-shaped curve indicating that extreme lean-
ness as well as obesity tends to associate with increased mortality
(Figure 1). As previously suggested, mortality data are more easily
interpreted when translated into years of life lost or gained (8)
and increased mortality of course means shorter life span. This
review will examine the knowledge gained from CR experiments
and attempt to reconcile these data with information gained from
epidemiological studies in humans.
The focus here will be exclusively on body weight and on its
relation to optimal health. With a given body weight of course,
other factors are potentially very relevant in modulating health
and life span, for example, diet composition and physical activity
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FIGURE 1 | U-shaped curve showing the relationship between
all-cause mortality and body mass index (BMI) in man. The curve was
drawn using data from the Prospective Studies Collaboration et al. (9). For
an explanation regarding the legend box and colored arrows, see the last
paragraph.
levels [see e.g., Ref. (10, 11) respectively]. Factors, these two just
mentioned, that can contribute to health and life span indepen-
dently from body weight and that are also capable, however, of
modulating body weight and body composition profoundly.
We will first examine growth and longevity studies followed
by an examination of lean body mass and longevity in several
species used for experimental studies such as rodents. This infor-
mation will be related to CR studies in primates, and finally to
epidemiological data in the human population.
GROWTH AND LONGEVITY
GROWTH AND LONGEVITY IN ANIMALS
Species with greater adult body mass tend to be longer lived
than species with smaller adult body mass, more precisely, with
every doubling of species body mass, there is, on average, a 16%
increase in maximum species life span (12). Within a single species,
instead, and inverse relationship exists between body weight and
lifespan. Citing the title of a study published by Miller and col-
leagues on this subject, we can say that in outbred mice, “big
mice die young,” or to be more specific, “early life body weight
predicts longevity” (13). Although, in rodents, this relationship is
not always clear (14–17), a large analysis of laboratory rats and
mice used for research in the twentieth century confirms these
conclusions showing a negative correlation between maximum
mature weight and maximum longevity (18). In other words,
inside a single species, development, the rate and/or the extent of
it, seems to be inversely related to longevity. A familiar species in
which we can observe this relationship rather well is one that has
been shaped for generations by human selective breeding, dogs.
Breeds that grow to considerable size, probably in part because of
high IGF-1 levels (19), tend to have shorter lifespans. For exam-
ple, the Saint Bernard has an average lifespan just above 8 years,
whereas the much smaller Chihuahua has an average life span of
more than 10 years (20). Additionally, there are many mutations
in mice in which small size is associated with increased longevity
[for a review, see Ref. (21)]. Ames Dwarf mice, for example, which
are homozygous for a recessive mutation in the Prop 1 gene that
causes hypopituitarism, weigh about one-third that of wild type
mice and show an average lifespan extension of ~50% for males
and 60% for females (22). Regarding hypopituitarism, we should
add for completeness, that ablation of pituitary hormones is able
to increase the lifespan of laboratory mice significantly even after
complete development has been reached (23). Reasoning on what
might explain the existence of such a trade-off between size and
longevity, we have proposed the idea that the availability of time
is key assets during development. A slower development (that can
result, although not necessarily, in smaller adult size) means, at
the cellular level, more time to complete every cell cycle (and of
course fewer overall cell cycles in the case of smaller adult size).
This should allow more time for error proofing in DNA synthesis
and for damage repair, preserving the genome for longer periods
and possibly extending lifespan (24). This relationship also has
been observed in mice selectively bred for differences in the rate of
body weight gain (25). More recently, in the short lived Berlin Fat
Mouse Inbred line 860, it has been observed a highly significant
inverse correlation between daily body weight gain and lifespan
(26). Additionally, the trade-off between growth rate and longevity
has been examined through experimental manipulation in fish. In
three-spined sticklebacks, exposure to different temperature or
photoperiod deflected normal growth trajectories. This induced
catch-up or slowed-down growth that led to a reduced or extended
lifespan, respectively (27). Finally, in a comprehensive analysis that
used the AnAge database (28), postnatal growth rate and adult life
span of 204 mammalian species are shown to be inversely and
statistically significantly related (29). The same study reports also
a positive and statistically significant relationship between time
to sexual maturity and adult life span among 606 mammalian
species, finding that is underlying again the importance of time
during development.
GROWTH AND LONGEVITY IN HUMANS
Humans seem to not escape this inverse relationship. For example,
baseball players weighing 80 or more kilograms have an aver-
age lifespan of about 61 years, whereas those weighing 10 kg less
have an average lifespan of about 66 years (30). The same rela-
tionship has been observed between different ethnic groups living
in California, where smaller size was associated with longer lifes-
pan (30). However, mutations that extend lifespan in mice may
not have the same impact in humans. Humans with a mutated
PROP 1 gene (similar to the Ames Dwarf) described on the
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Croatian island of Krk exhibit seriously compromised develop-
ment. Although these individuals can reach advanced age, extreme
longevity has not been reported (31, 32). From other available
human studies, it appears that dwarfism, despite a reduced cancer
risk (33), does not associate with increased lifespan [reviewed in
Ref. (34)]. Studies analyzing human growth complicate the pic-
ture, showing that stunted or reduced growth during childhood
due to poor nutrition and/or a higher infection load is associated
with a decrease in lifespan, not an increase (35, 36). Although
longevity data from human dwarfism and child growth stud-
ies suggest caution in drawing general conclusions, one possible
hypothesis might be drawn from the studies thus far reviewed:
factors with a positive effect on development, such as GH/IGF-
1 and thyroid hormones, might negatively affect survival later
in life. This could be an example of antagonistic pleiotropy (37)
with beneficial effects on fitness early during lifespan and negative
effects later. To this consideration, we should add that women are
in average smaller than man and generally longer lived [reviews
in Ref. (38)]. That size might partially account for the gender
longevity benefit has in fact already been proposed (39, 40). Addi-
tionally, centenarians tend to be shorter than non-centenarians
at 30 years (41). Finally, nonagenarians with greater body weight
tend to have skin fibroblasts with less residual proliferative capac-
ity compared with their smaller contemporaries, suggesting that
larger bodies use more cellular replicative capacity during devel-
opment, leaving less replicative potential for tissue maintenance
during adulthood (42). This last finding is more relevant for the
present discussion if we consider that the major determinant for
skin fibroblast replicative capacity among species is size and not
longevity (43).
This short overview of the relation between growth and
longevity is of course incomplete. For more in depth reviews on
the correlates between aging phenotypes and cellular phenotypes
with a specific emphasis on cell proliferation, see Ref. (44, 45).
LEANNESS AND LONGEVITY
LEANNESS AND LONGEVITY IN RODENTS
The development of adipose tissue may be dampened by either
physical activity or CR. In fact, adipocyte hyperplasia is signif-
icantly reduced if weight gain of Wistar rats is controlled by
forced swimming or CR. If treatment is terminated in adulthood
(28 weeks) and these animals begin to eat the same amount of
food as sedentary control animals fed ad libitum throughout life,
they will indeed significantly increase in weight, but will be unable
to reach the same body weight as the control group, even at the
advanced age of 62 weeks. This is mainly due to the reduced cellu-
larity of adipose tissue during development caused by either of the
two treatments (46). Masoro, studying Fischer 344 rats, reported
that CR reduces the number of fat cells in fat depots when started
soon after weaning or in adult life and that the capacity of CR
to modulate fat cell number is maintained through most of the
lifespan (47), indeed, differently from it seems to be the case in
man (see below), in rats adipocytes numbers keeps on increasing
even during adult life in ad libitum fed animals, at least this is
the case for the Fisher 344 and the Wistar strains (46). Teillet and
colleagues investigated the effect of CR on a lean strain of rats
(WAG/Rij) and have concluded that food restriction initiated in
adults most efficiently increases survival in rodents with a high
spontaneous food intake (i.e., the majority of laboratory strains),
but has a minor effect on lean strains (48). Liao et al. (6), measur-
ing fat loss in 41 recombinant inbred strain of mice where CR was
started in early adulthood (2–5 months of age), have obtained the
opposite result. Strains with the least reduction in fat were more
likely to show life extension after CR while those with the greatest
fat reduction were more likely to undergo to lifespan shorten-
ing. Rodents with specific mutations that affect the adipose tissue
complicate even more the picture. Genetically obese ob/ob mice
are extremely fat (67% of body weight is fat) and short lived. They
have been calorically restricted by receiving an amount of food so
that they maintained their weight at a similar level of ad libitum fed
normal mice. Surprisingly, they resulted longer lived than ad libi-
tum fed wild type mice, and had similar longevities of equally
food-restricted wild type mice although still 48% of their body
weight was fat (49). Genetically altered mice that lack white adi-
pose tissue result short lived (50) or diseased (51), but mice with
a mutation that ablates the insulin receptor in adipose tissue are
extremely lean and live significantly longer than wild type con-
trols (52). Summing up the reports here reviewed, it is difficult
to indicate a clear relationship between leanness and longevity for
rodents.
LEANNESS AND LONGEVITY IN MONKEYS
Studies in primates, of course, are of extreme relevance for under-
standing human endocrinology. In free-ranging human fed rhesus
monkeys of the Cayo Santiago island of the Caribbean Primate
Research Center, it is possible to observe obesity with abdominal
fat accumulation (53); this indicates that macaques may have the
same natural propensity for central obesity as humans do. Two
large CR studies are ongoing in rhesus monkeys; one at the Wis-
consin National Primate Research Center (WNPRC) in Madison
(54, 55) and one at the National Institutes on Aging (NIA) in
Bethesda, MD, USA (56). The application of CR is quite differ-
ent in the two studies. The WNPRC study is conceptually more
similar to a rodent study of CR started in adulthood. Fully devel-
oped monkeys assigned to the CR group were allowed free access
to food for 3–6 months to determine their individual ad libitum
intake. The CR diet consisted of their ad libitum intake reduced by
30%. In the NIA study, the control group of monkeys, once adult
received a diet that prevented the appearance of obesity; in other
words, they were not fed ad libitum as in the majority of rodent
studies and the WNPRC study. The NIA CR group received a 30%
reduction in caloric intake of their obesity-preventing diet. The
difference in diet protocol between the two studies had a signifi-
cant impact on body weight. At 17 years, WNPRC males weighed
about 12% more than corresponding NIA males. The difference
for females was about 18%.
Even with some monkeys still alive in both studies, expected
overall results have been published. In the WNPRC study where
CR monkeys weighed about 25% less than controls, mainly due
to a reduction in body fat (57), a significant increase in aver-
age and maximum lifespan is observed (55). In the NIA study
where CR monkeys also weighed about 25% less than controls
(58), no significant increase in average or maximum lifespan is
expected (56).
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LEANNESS AND LONGEVITY IN HUMAN
In humans, the influence of body fat on health has been since
long time under scrutiny. Thanks to the ease with which it can
be calculated, BMI is one of the anthropometric measurements
most commonly used in epidemiological studies to assess overall
body fat. However, its limitations are well known. For example,
the BMI of an athlete may be in the range of obesity even if the
subject has an exceptionally low percentage of body fat, due to
the weight of a large lean body mass. In other words, BMI gives
a very imprecise estimate of a person’s physical activity level, the
importance of which has been since quite some time recognized in
contributing to a successful aging (59) and can indeed significantly
increase survival (11); for a recent discussion on the limits of BMI,
see Ahima and Lazar (60). Notwithstanding these limitations, for
large cohorts, BMI gives a good representation of leanness or lack
thereof in a population (61). A recent, very large meta-analysis has
shaken the epidemiological community by showing that the lowest
inflection point for the BMI–mortality curve (its nadir) lays in the
overweight range (62). Discussion is ongoing among epidemiolo-
gists on this topic, some time referred to as the “obesity–mortality
paradox.” There are several confounding factors, in fact, to con-
sider: for example, smokers tend to weigh less but have higher
mortality (63); some chronic diseases may induce weight loss; the
frail elderly with higher risk of death may also experience weight
loss, etc. For a recent detailed review on this point, see Fontana and
Hu (64). The issues of determining which of the two categories,
normal or overweight, have the lowest mortality is of course highly
relevant for the present discussion. However, even if we disregard
this issue and observe the shape of the mortality curves with a
higher resolution of the BMI scale that the one offered by the
standard BMI categories, the difficulty of reconciling CR animal
data with human epidemiological data becomes apparent. Start-
ing from what is well known, it is clear that being underweight
is associated with increased mortality and consequently reduced
life expectancy. For example, from survival curves of patients with
anorexia nervosa, it can be calculated that a person suffering from
this disorder since the age of 15 years will endure a life-shortening
effect of 25 years (65). What is not clear is where exactly the nadir of
the curve lays and which curve should be used as reference for pol-
icy making decisions regarding social health. Of course, there are
several important factors to keep in mind. For example, the nadir
differs based on age. Andres (66) reported a rise in BMI from 21.4
for people aged 20–29 years to 26.6 for those aged 60–69 years. In
another study, Matsuo et al. (67) reported an ~two-point increase
in BMI moving from the 40- to 59-year age group to the 60- to
79-year group in both men and women. Additionally, data show-
ing that the nadir for women tends to be lower than that of men
(68) suggest that BMI categories should be different according
to gender. Finally, the use of different reference curves might be
appropriate based on ethnicity [on this last point, see for example,
the studies listed in Table 1 and Ref. (69)]. Notwithstanding these
complications, from the epidemiological literature it appears that
the nadir of the curve does not lay in the middle of the normal
range, but tends to lay near its upper limit if not above it, as pre-
viously mentioned. See Table 1 for an incomplete list of studies in
which the BMI–mortality curve rise descending the normal range
from 24.9 to 18.5.
An important question that gerontologists and epidemiologists
should try to answer together is the following: “people who volun-
tarily choose a CR regimen and are already within a normal BMI
Table 1 | Studies showing increasing mortality with decreasing BMI inside the normal BMI range (18.5–24.9).
Study title Size of population
analyzed (millions)
Notes Reference
Association of all-cause mortality with overweight and
obesity using standard body mass index categories: a
systematic review and meta-analysis
2.88 Meta-analysis of 97 studies Flegal et al. (62)
Body mass index and mortality among 1.46 million white
adults
1.46 Meta-analysis of 19 studies,
non-Hispanic white participants
Berrington de Gonzalez
et al. (70)
Body mass index and cause-specific mortality in 900 000
adults: collaborative analysis of 57 prospective studies
0.9 Meta-analysis of 57 studies,
participants mainly of western
Europe and North America
Prospective Studies
Collaboration et al. (9)
Shape of the BMI–mortality association by cause of death,
using generalized additive models: NHIS 1986–2006
0.26 Non-Hispanic white participants Zajacova and Burgard (71)
Body mass index and mortality in China: a 15-year
prospective study of 220,000 men
0.22 Chinese cohort Chen et al. (72)
Body mass index and mortality: results of a cohort of
184,697 adults in Austria
0.18 Austrian cohort Klenk et al. (73)
Body weight and mortality among men and women in China 0.17 Chinese cohort Gu et al. (74)
BMI and all-cause mortality among Japanese older adults:
findings from the Japan collaborative cohort study
0.027 Japanese cohort Tamakoshi et al. (75)
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range, let us say its upper half, are increasing their longevity or
their mortality?”Indeed, when glancing on reports about members
of the Calorie Restriction Society, or CRONies (Calorie Restric-
tion with Optimal Nutrition) as they call themselves, we should
consider their BMI. In one of the longest studies available, for
example, where subject were monitored for a period of 6 years, 28
weight-stable CRONies had an average BMI of 19.7, and they were
compared with 28 age-matched subjects on a typical western diet
who had an average BMI of 25.6 and served as the control group
(76). These two groups, for example, had BMI values that quite
precisely spanned the normal BMI range. If these two groups of
persons will keep their body weight constant for the future, what
could we predict regarding their longevity? Using as guidance stud-
ies like the ones reported in Table 1, we should conclude that the
control group should experience a lower mortality. Instead, using
as guidance the generally accepted idea that CR extend laboratory
animals life span together with the few available prospective stud-
ies where persons who were leaner in youth or in midlife resulted
longer lived (77, 78), we should conclude that the CRONies will
actually experience decrease mortality and extended longevity.
To complete this short overview on human leanness, we should
mention that recent data on body fat cellularity indicate that
humans may behave as rodents during development (i.e., more
available calories – more adipocytes), but a little differently in
adulthood. Spalding et al. (79) reported that ~10% of fat cells are
renewed annually in adults at every BMI level in humans. How-
ever, the number of fat cells remains constant in adulthood in both
lean and obese individuals, and obese individuals that undergo
bariatric surgery lose a significant amount of weight and body fat,
but not fat cell number.
WILD AND HYPOTHETICAL CONSIDERATIONS
WILD CONSIDERATIONS
Wild mice housed in the laboratory for four generations under
ad libitum conditions eat less than control mice of several strains
used in CR experiments (80) and when these wild mice are sub-
jected to CR, they do not benefit from extended longevity (81).
Wild rhesus monkeys in their habitat result lighter even then CR
monkeys of the NIA and WNPRC studies described above (82) and
at least for the WNPRC study, the difference in weight between the
CR and ad libitum groups is more a result of weight gain in the
control monkeys than weight loss in CR monkeys (83). Altmann
and colleagues report that baboons with accessible abundance of
food had in average a 23.2% of body fat while wild-feeding animals
had only a scarce 1.9% (84). Young adult WNPRC Rhesus monkeys
have average body fat above 10% already at the beginning of the
study (85). The percent of body fat of these monkeys then quickly
increases during their adult life; and this it does happen, although
in a lesser degree, even in the CR animals; for the majority of their
adult life, indeed, body fat appears to be around: 30% for control
males, 20% for CR males, 20% for control females, and 13% for
CR females (57).
These data suggest that laboratory strains of rodents have
been inadvertently selected for higher caloric intake and con-
sequently for higher percent of body fat (80). An interesting
meta-analysis on the universality of CR among all tested species
suggests that this husbandry selection bias could explain why the
mot significant effects of CR are observed in models species: mice
and rats,Drosophilamelanogaster,Caenorhabditis elegans, and Sac-
charomyces cerevisiae (3). The sedentariness imposed by the close
confinement of captivity also may contribute to a higher percent
of body fat because energy expenditure may not be correctly bal-
anced with food consumption; at least this is true in male rats (46,
86, 87). For monkeys, in addition to low energy expenditure, we
should consider that in the WNPRC and NIA studies the animals
are housed individually and in very small cages [in the WNPRC
study, cage volume is of 0.66 m3 (88)]. Social isolation may over-
stimulate food consumption as a compensatory mechanism of the
reward limbic system due to life conditions that can understand-
ably carry intelligent animals toward depression. Indeed Luppino
et al. (89), in a recent meta-analysis, conclude that obesity and
depression are reciprocally predictive. Finally, in northern Tanza-
nia, the Hadza, who are one of the last remaining human hunting
and gathering communities of the world have an average BMI of
20.2 for man and 20.4 for woman (90).
HYPOTHETICAL CONSIDERATIONS
Considering all of the above and adding that WNPRC male control
monkeys weigh about 9% more than the average of captive mon-
key housed in research facilities across the US [see Ref. (55); and
the iPAD database http://ipad.primate.wisc.edu], we may consider
a control monkey of the WNPRC study as equivalent to a moder-
ately obese man. Then, using the available data from the monkey
studies [see Supplementary Table 2 of (56) and reference there in],
propose the following speculation. Consider a 1.7 m tall reference
man weighing 70 kg (91) with a BMI of 24.2 (in the upper half of
the normal range). Then, imagine him obese, for example, 90 kg
with a BMI of 31.1. We can use this man as the“man equivalent” of
the WNPRC control monkey. The WNPRC CR “man equivalent”
will weigh 25% less and consequently, will have a BMI of 23.4 (still
in the upper half of the normal weight category). WNPRC male
monkeys weighed ~12% more than corresponding NIA males so
the control “man equivalent” of the NIA study will have a BMI
of 27.7 and be in the overweight category. CR in the NIA study
reduces body weight by 25%, so the NIA CR “man equivalent”
will have a BMI of 20.8 (in the lower half of the normal weight
category). Recapping and considering the recent literature on the
relation between mortality and human BMI, it is possible to sug-
gest that the WNPRC study showed a significant health advantage
of the CR monkeys as a significant advantage can be effectively
observed between obesity and normal weight in all-cause mortal-
ity in the vast majority of epidemiological human studies. On the
other end, CR on the NIA monkeys fails to show a clear life span
benefit as several human studies fails to show a clear advantage
between the overweight category and the first half of the nor-
mal weight range (see an explicative scheme of this argument in
Figure 1). In pondering this hypothetical parallel between humans
and Rhesus monkey, let us consider also that only 10% of CR is
equivalent to a restriction of 25% in increasing rats’ life span (92).
Of course, this is just one possible explanation in trying to
reconcile animal data on CR and human epidemiological studies.
It is an explanation that brings us back to a not new considera-
tion: the one that caged animals with ad libitum feeding should
be considered to be in an “obesogenic” instead of in a “normal”
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or “control” condition (93), a concept more recently reviewed by
Martin et al. (94). The hope of this short review is that more in
depth analysis will follow on this important matter. To better inter-
pret animal CR studies, for instance, it could be useful to generate
(for monkeys, for example, using resources such the iPAD just
mentioned), mortality versus % body fat or mortality versus BMI
curves for ad libitum fed control animals. Indeed, reference body
composition values for adult rhesus monkeys have been already
proposed (95).
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